Oxbryta Recall Announced After Studies Show Sickle Cell Drug’s Risks Outweigh Benefits
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
September 26, 2024 By: Martha Garcia
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
As part of a new attempt to resolve tens of thousands of talcum powder cancer lawsuits for about $8 billion, Johnson & Johnson has initiated a third bankruptcy filing, this time involving its subsidiary Red River Talc.
A Mounjaro lawsuit claims Eli Lilly failed to warn patients that gastroparesis side effects could result in cyclical vomiting lasting more than a year.
Federal judge has ordered plaintiffs to propose a single talcum powder cancer lawsuit for the first federal bellwether trial, which is scheduled to begin in December.
"*" indicates required fields